Scientific Publications and News Articles

  1. Maternal RSV Task Force Emphasizes the Immediate Opportunity to Protect All Infants in Canada from RSV Disease
  2. Healthcare Providers and Pregnant People’s Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial Virus
  3. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case–control study
  4. Maternal vaccination to prevent severe RSV disease in infants
  5. Respiratory syncytial virus vaccination in pregnancy (cmaj.ca)
  6. Nirsevimab to reduce infant morbidity from respiratory syncytial virus (cmaj.ca)
  7. New RSV vaccine could prevent 5,000 infant hospitalisations – GOV.UK (www.gov.uk)
  8.  Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada – ScienceDirect
  9. Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial
  10. Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine 
  11. High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility – ScienceDirect